Summary
We report about a 72–year–old woman who was admitted to our hospital because of an acute ST–elevation myocardial infarction (STEMI). At admission, she received a loading dose of 300 mg Clopidogrel and 500 mg aspirin (ASA) prior to angioplasty with stenting of a 90% diameter stenosis of the proximal right coronary artery. After intervention, 75 mg Clopidogrel and 300 mg ASA OD were continued. Three days later, she developed a recurrent acute STEMI due to stent thrombosis and a second stent implantation was performed. The dose of Clopidogrel and ASA remained unchanged. Three days later, the patient suffered a third STEMI due to a restent thrombosis and additional stent implantation was performed. The dose of Clopidogrel and ASA was increased to 75 mg BD and 500 mg OD. Platelet function analysis and aggregation studies demonstrated dose–independent ASA resistance. ADP–induced aggregation showed a short–term platelet inhibition with subsequent rapid normalisation, thus suggesting Clopidogrel resistance. Therefore, the treatment was changed to coumadin and ASA 100 mg OD. Since then, the patient has been clinically stabile. Our case indicates for the first time the existence of a subgroup of patients with combined Clopidogrel and ASA resistance. We conclude that identification of these patients is required and alternative therapeutic options have to be considered.
References
Born GV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929
Cattaneo M (2004) Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol 24:1980–1987
Elsasser A, Nef H, Mollmann H, Hamm CW (2005) Clopidogrel in acute coronary syndrome: when, how much, how long? Z Kardiol 94:377–382
Gum PA, Kottke–Marchant K, Welsh PA, White J, Topol EJ (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41:961–965
Kawata M, Kuramoto E, Kataoka T, Saito A, Adachi K, Matsuura A, Sakamoto S (2005) Comparative inhibitory effects of cilostazol and ticlopidine on subacute stent thrombosis and platelet function in acute myocardial infarction patients with percutaneous coronary intervention. Int Heart J 46:13–22
Kubler W (2004) Primary prevention of coronary heart disease with aspirin. Z Kardiol 93(Suppl 2):II33–36
Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109:3171–3175
Wiviott SD, Antman EM (2004) Clopidogrel resistance: a new chapter in a fastmoving story. Circulation 109:3064–3067
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Templin, C., Schaefer, A., Stumme, B. et al. Combined aspirin and Clopidogrel resistance associated with recurrent coronary stent thrombosis. Clin Res Cardiol 95, 122–126 (2006). https://doi.org/10.1007/s00392-006-0332-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-006-0332-8